×
You will be redirected back to your article in seconds

The Bourne Legacy

Subbing character actor Jeremy Renner into a franchise that requires Matt Damon-caliber magnetism, series scribe Tony Gilroy takes over the helming duties with an overlong sequel that features too little action and an unnecessarily complicated plot.

With:
Aaron Cross - Jeremy Renner
Dr. Marta Shearing - Rachel Weisz
Ret. Col. Eric Byer, USAF - Edward Norton
Ret. Adm. Mark Turso, USN - Stacy Keach
Terrence Ward - Dennis Boutsikaris
Outcome #3 - Oscar Isaac

Jason Bourne is nowhere to be found in “The Bourne Legacy.” Instead, the villains’ storyline continues as ruthless government agencies try to decommission an entire line of Bourne-like super-soldiers, but fail to eliminate one: Aaron Cross, an agent whose name is far punchier than his personality. Subbing character actor Jeremy Renner into a franchise that requires Matt Damon-caliber magnetism, series scribe Tony Gilroy takes over the helming duties with an overlong sequel that features too little action and an unnecessarily complicated plot. Fans will come, but they won’t be happy, as if paying for a Bond movie and getting a 002 adventure in return.

After director Paul Greengrass walked away and Damon declined to reprise his most popular character, the producers were left with a sizable challenge, the sort creator Robert Ludlum clearly never faced in his novels. Rather than risk recasting the role, the filmmakers tapped Gilroy (who had written all three prior installments) to create a fresh agent in Bourne’s image, introducing Renner’s character with the tagline “There was never just one.”

But Gilroy is a different kind of director from Doug Liman and Greengrass, less interested in explosions than in the mechanics of the bomb. Putting him in charge amplifies the backroom dealings (this time, it’s Edward Norton running the show from a Virginia-based crisis suite), to the detriment of the scenes featuring the franchise’s new protagonist.

Aaron Cross (Renner) belongs to a companion program, Outcome, similar to Bourne’s Treadstone, except that its genetically modified operatives are controlled by means of two pills: The blue capsules boost brain functioning, while the green ones improve their physical performance. When the supply runs out, the agents regress to their unmodified state, a prospect unappealing enough that Cross, trained to assassinate at the CIA’s whim, will kill to continue his dosage.

To get more drugs, Cross must locate Dr. Marta Shearing (Rachel Weisz), who barely survived a brutal workplace shooting in a scene that would be disturbing enough without Aurora, Colo., still fresh in the mind. Theatrical line readings aside, Shearing behaves realistically under pressure, fighting off panic while Cross tries to protect her until the very end, when the film gives her a chance to assert her own survival instinct.

Though the espionage genre traditionally favors action, Gilroy is clearly more of a blue-pill kind of guy, having actively resisted standard spy-movie cliches since the series’ beginning. But the helmer pushes too far in the opposite direction here, resisting an opening-scene adrenaline rush and supplying clues in stingy portions more likely to frustrate than to flatter auds’ intelligence. Indeed, half an hour unspools before the action kicks in, and longer than that before things start to make sense.

Renner features throughout the first act, but his hazy character has been dispatched to remote Alaska on an ambiguous training exercise. While Cross slogs through the snow, Norton’s cold-blooded power broker, Eric Byer, cleans up the mess exposed by Bourne, whose one-man vendetta compromised not only not only Treadstone but Outcome as well.

In “The Bourne Identity,” the hero’s amnesia mirrored that pic’s way of dispensing information, effectively putting auds in Bourne’s shoes. Repeated on a character with a functioning memory, the approach feels like a tease, as Gilroy’s script (co-written with brother Dan) not only withholds crucial exposition, but wrongfully assumes that auds will automatically care about Bourne’s replacement.

Renner comes across as less immediately compelling than Damon, partly because it takes so long for the story to focus on Cross, and though the actor portrays a man in turmoil, the film fails to get inside his head. Outside, photos of Bourne flash by on surveillance monitors or clipped to files, suggesting that a more interesting film — namely, “The Bourne Ultimatum” — is unfolding elsewhere at the same time. Series regulars Albert Finney, Joan Allen and David Strathairn cycle by in the background, but this installment is wedded to the fate of Outcome.

An around-the-world montage introduces the program’s five other agents, whose mix of races and genders might have been intriguing, had Byer not succeeded in snuffing them out so quickly. These assassins typically work alone, which makes for a tense meeting when Cross encounters his first fellow Outcome agent (Oscar Isaac).

Unlike Bourne, Cross knows what he is and can fairly deduce who might be trying to kill him, but his top priority is finding a way to “viral out,” relying on Shearing to administer the serum that will make his enhancements permanent. To do so, they must travel to Manila, where “The Bourne Legacy” finally decides to become a Bourne movie, clumsily trying to squeeze as much action into the final reel as possible. If the filmmakers hope to carry on with Cross, they will have to rethink what auds expect from the character, offering more confrontation and less conspiracy.

Gilroy reassembles much of his “Michael Clayton” team, relying on composer James Newton Howard to help goose the energy. The combination of Robert Elswit’s elegant widescreen lensing and the measured editing by Gilroy’s brother John may be easier to absorb than Greengrass’ hyperkinetic docu-based style, but the pic’s convoluted script ensures that auds will emerge no less overwhelmed.

The Bourne Legacy

Production: A Universal release presented in association with Relativity Media of a Kennedy/Marshall production in association with Captivate Entertainment. Produced by Frank Marshall, Patrick Crowley, Jeffrey M. Weiner, Ben Smith. Executive producers, Henry Morrison, Jennifer Fox. Directed by Tony Gilroy. Screenplay, Tony Gilroy, Dan Gilroy; story, Tony Gilroy, inspired by the "Bourne" series created by Robert Ludlum.

Crew: Camera (Deluxe color, Panavision widescreen), Robert Elswit; editor, John Gilroy; music, James Newton Howard; production designer, Kevin Thompson; supervising art director, Molly Hughes; set decorator, Leslie Rollins; costume designer, Shay Cunliffe; sound (Datasat/SDDS/Dolby Digital), Kirk Francis; supervising sound editor, Per Hallberg; re-recording mixers, Gary Summers, David Parker; special effects supervisors, Garry Elmendorf, Steven Kirshoff; visual effects supervisors, Hal Couzens, Mike Ellis; visual effects, Double Negative, Level 256, Rhythm & Hues Studios, Phosphene, Lola VFX; stunt coordinator, Chris O'Hara; associate producer, Daniel M. Stillman; assistant directors, Steve E. Andrews, William M. Connor; second unit director, Dan Bradley; casting, Ellen Chenoweth. Reviewed at the Landmark, Los Angeles, Aug. 2, 2012. (In Deauville American Film Festival.) MPAA Rating: PG-13. Running time: 135 MIN.

With: Aaron Cross - Jeremy Renner
Dr. Marta Shearing - Rachel Weisz
Ret. Col. Eric Byer, USAF - Edward Norton
Ret. Adm. Mark Turso, USN - Stacy Keach
Terrence Ward - Dennis Boutsikaris
Outcome #3 - Oscar IsaacWith: Joan Allen, Albert Finney, David Strathairn, Scott Glenn.

More Film

  • FX's 'Snowfall' Panel TCA Winter Press

    John Singleton Hospitalized After Suffering Stroke

    UPDATED with statements from John Singleton’s family and FX Networks John Singleton, the Oscar nominated director and writer of “Boyz N’ the Hood,” has suffered a stroke. Sources confirm to Variety that Singleton checked himself into the hospital earlier this week after experiencing pain in his leg. The stroke has been characterized by doctors as [...]

  • 'Curse of La Llorona' Leads Slow

    'Curse of La Llorona' Leads Slow Easter Weekend at the Box Office

    New Line’s horror pic “The Curse of La Llorona” will summon a solid $25 million debut at the domestic box office, leading a quiet Easter weekend before Marvel’s “Avengers: Endgame” hits theaters on April 26. The James Wan-produced “La Llorona,” playing in 3,372 theaters, was a hit with hispanic audiences, who accounted for nearly 50% [...]

  • Jim Jarmusch in 'Carmine Street Guitars'

    Film Review: 'Carmine Street Guitars'

    “Carmine Street Guitars” is a one-of-a-kind documentary that exudes a gentle, homespun magic. It’s a no-fuss, 80-minute-long portrait of Rick Kelly, who builds and sells custom guitars out of a modest storefront on Carmine Street in New York’s Greenwich Village, and the film touches on obsessions that have been popping up, like fragrant weeds, in [...]

  • Missing Link Laika Studios

    ‘Missing Link’ Again Tops Studios’ TV Ad Spending

    In this week’s edition of the Variety Movie Commercial Tracker, powered by the TV ad measurement and attribution company iSpot.tv, Annapurna Pictures claims the top spot in spending for the second week in a row with “Missing Link.” Ads placed for the animated film had an estimated media value of $5.91 million through Sunday for [...]

  • Little Woods

    Film Review: 'Little Woods'

    So much of the recent political debate has focused on the United States’ southern border, and on the threat of illegal drugs and criminals filtering up through Mexico. But what of the north, where Americans traffic opiates and prescription pills from Canada across a border that runs nearly three times as long? “Little Woods” opens [...]

  • Beyonce's Netflix Deal Worth a Whopping

    Beyonce's Netflix Deal Worth a Whopping $60 Million (EXCLUSIVE)

    Netflix has become a destination for television visionaries like Shonda Rhimes and Ryan Murphy, with deals worth $100 million and $250 million, respectively, and top comedians like Chris Rock and Dave Chappelle ($40 million and $60 million, respectively). The streaming giant, which just announced it’s added nearly 10 million subscribers in Q1, is honing in [...]

More From Our Brands

Access exclusive content